Europe Moves to Make Drug Trial Data More TransparentBy
Drug researchers in Europe would be required to publish results from all medical trials under a proposed law that the European Parliament will vote on Wednesday. The new rules are meant to curtail pharma companies from cherry-picking favorable studies to get new medicines approved.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.